# Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

> **Open Intelligence Dossier** · First detected: 2026-09-21 18:00 UTC · Category: Business

## Executive Summary
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production" is generating significant coverage in the Business category, with 6 articles from 6 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Seeking Alpha, Healthcare Asia Magazine, Yahoo Finance and KSL News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | Lilly CEO Dave Ricks says Foundayo winning new pill patients | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxQb21pZ1BjNWpWZ0Jfd3FaSW0yX1NKeTk0Uk5FZU55aUFJN1ZXMndPaTZXallsMDhMOTFpbmJnVUVTNTRlSzBZcVhNOU9yM2VOdV90QW1UMWJMMklqRl8ydi1NMW9KVUhDdXliQjEtWTJBVndQeGszT3A5NWZ6RTRjcktBcFk4UVVkWFZwUHpfRQ?oc=5) |
| Houston Chronicle | The company behind a new GLP-1 pill is betting $6.5 billion on Houston | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNUJqVWhITlZLN2lKOGdsVGN1V091WTBXZkJ1dEt6dGVqZE82T3B1anJpRGljV2taMFlLdDRtRnJkM1hhcU14aU1ZVWZQaU1jU3dsN255UElObVVaQ3QxeU1XZlB2Umd6RUUzSlVOZGwzTDF1MXJiU291UFM2Q1JueXFVTlhkWnhPV0ZhQUlCQkQyZmw1UmUxS0NTUFRJM0F5dlctb1VoZ1JaTjB3aFE1Y3F4RHp6N3Zq?oc=5) |
| The Business Journals | Eli Lilly breaks ground on $6.5B Houston plant, largest project of its kind in Texas history | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxOc2wyNmtmWDg4TmhoQXB6Ri1GZFhBeDkzZ1IxOFA2M0YtMlp6SGFiUWN6MGVhbWFjT2llWWNaSkRXRE9HVWp2aThrS3N0T0ZVRE9sazFRb0IzbTh5b0YyMWd6dlhjUDQ1WXpsTEYwQXQ3NTlEYlI4bGFHTF9XNjZCQVJ1dTFZc3BaUnJ1WkJ2X0x0bi1qSGxaZHJWVnRGMTFFMFUxVFZR?oc=5) |
| KHOU | Eli Lilly is breaking ground in Houston on a facility planned for 2030 | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZlJONE9TVE5TTXgwMkdzSUpjOHFaWFM2Nmw5MFlzblBpM2tFNjZGc3RDNWRmQW14SkhGZG5Ld2tPaXZMSXVBc2NfSVFNUHpCTkZkakdwbktjejFPUGtOaVhkMnNrR1JpYVQ4ZS1lTU1yU3M0bmhTeGFOMms1MEEyM2pqRGFsclpiaGFTcEVHVm9mMzh5ZEUycDlKMVdvY1k4ZXdLN1pOZVAzNG4tdldPQW5hc0FCNHRaZDUtZzVlOWE?oc=5) |
| TradingView | Eli Lilly CEO Ricks sees more Foundayo growth with foreign markets | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxQcVgxZjQtejFWT3FGZGlmMzV3bjZxVEJOcHdZVVgyR0lkUlNNZnFFTXQzZUFIZm4yWEluNHNKMkRjUnBkUmF3LTdyMFlybGlfTTViLUhfZHV0aTQ4RVhRM0xLdU1weml2RUVHdWZCcE9HU0Q3Y25xaUo1YTdnYU5CMWQzVE8xeW40cnhWQ2x0c21xNF80UTNqUTY3RWd0cERjNHdWZS14SndkMV9hNzQydHhxUWFydm1zTlZPRmFOMmhPTVAzU0JLTg?oc=5) |
| TipRanks | Eli Lilly Stock (LLY) Rises After Company Provides Update on Obesity Pill Sales | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxOSkd5eHZxVndublVfdHk2ekJ2MWczU0ZHakh2ZHhLcXQwSkJUN2NrNFE0VnNXUWEtaUJyTU5fblFPV2NZd2tMMHpoLTV4bThUTW00Ylc4dl9PUks5Qm00M19od1Bsa1ZHSk9pREZuYU80R0dxZ1VzcUg4d1NvUFNiZWlLUTNTRDliV0hzMnlhSGlHZU5PTTNOOXV5SnYySE5zc1JkZmowYkVxVTQ?oc=5) |
| Investing.com | Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up By Reuters | [Source Link](https://news.google.com/rss/articles/CBMi3wFBVV95cUxNVE9UNFNHejFYaERnenBZbGNyRTkzWThwUzRtdDVtS1pwaS1NU0UzbHp4cHRSaVhoUE1XdVBPR1FGSm95SlBTWktDWi1OTm5lV1VLRDlmNThvb205aWlhdFNXX1QzaHdORE5rMWEzc1FSQnFjeUdpNHhkWFUwRVFTWFBCZTVVcGhfalpzOWIwTGdkMTVmb1hJby1pbF81dUhiUThtZmlsVVgxSllxajhGY1BTVjVGQ3EyRkdOQS05VnhKb2pBYmphQ3BpUzZtQ1F2SEcyeG9wOFl6dTMtdjdj?oc=5) |
| Reuters | Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs | [Source Link](https://news.google.com/rss/articles/CBMizAFBVV95cUxOek55cURnNVVRbTZMOEdZTEpWaGdrc2s4Njk1RF9UTzZ5WTBURU9nUFZqeHdwVXhILUktelE2Tm82NGF3WEVGenlpOHczajhNUUw5WXVDS1p1LWdFRFFvUnpkQV80c0ZYelNCY182N0pQbnJoVzJPcUZrZnpQb0hPWmFBa1ZxTVZ2UllSWU5iVFVWc1dyWWtubE5mdndtT2pSM1piaG1fdG1XcDNjZzIwOWF4Yjc4MDIzYXZLTkJlbC10QUxSbGVLMGQyRW4?oc=5) |
| Seeking Alpha | Eli Lilly CEO Ricks sees more Foundayo growth with foreign markets | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxPZVNkemFOUlhYOGRTRTNod3ZwUU9vM1dycEJMbmhSMFM4MHlHZUFpMWZfQjdyWFZob3c3WVR1MXBuUENfTkpycTVQYkpUSzVrX09fMXVPd1NydEk2VG1NZy1lR3lBb2N2MG5GZ2tHYzhEMEdUNUp6VGNTcW8ySjVmWU9wNGh4LWJGRF9iaVhCbWtwSG5mZGxUYTZTRnhzdVRa?oc=5) |
| Healthcare Asia Magazine | Obesity drugs market to grow 27% across 7MM by 2036 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxPN0pEWlpDeVVkNXdaRmdObHNIMVZ1WHU0YWNMZVd3bTlrd09mZHdMT1VYdGUwYVJ2UzlJQzM1YVV2Ulo2U0xSbDJCUGpvaVVQUWlqYW1EZlVTMU4wUWZFeEhlY0ZKTUpJVnpLbm1pNTY3eFZCNU5FeUxfT3FpWEVFUWtxcTE3S2hfRHRfU295WmNZSlNlUGhvOEZROA?oc=5) |
| Yahoo Finance | Lilly’s Obesity Access Push via Medicare Bridge Might Change The Case For Investing In Eli Lilly (LLY) | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPbUVlWS1IZTZlOEIxUzJKOTJKU1lIY0F0dWZsdFN2UTVHT2VTY3dDOHBwbHA3VzlmX3hpcFZZU0k2YmFnaVRVT0lSQk84cHlSbmJ1S2tsa2FNaUllZVZRWk5yWnVneHJJbnBEaGE5bEhvVEFtbzJScHdITDlPOC1xVWdVN2hYeEdTNWZFT0c5Vi1iSjF0?oc=5) |
| KSL News | Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up | [Source Link](https://news.google.com/rss/articles/CBMixwFBVV95cUxNc0JBVkc5c285NmpYekxRUk1iMGF0dElyRUhnam1rNE0tX3puSm1BUC04Q3Y0TWJkMm1TZmJONzNxUndYSUJSTHR2bEF3dGNRZGw5VnR2V19TbF96aXkzU2xKRGtrYk5zTi1PeElVR0RWcWM5N3F4YlNJNGNRbHo3UEc5R0hoQU1IM0tGb0dVcXpLRV9HRkwxY2ZlZHp5OUVlSzRRWGQwMll4dDRtcThUZExqRkMtY1FPQ3VlLVl2ZWYwbVNMem9R?oc=5) |
| qz.com | Lilly's Foundayo pill wins over a third of new patients, CEO says | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxOdWRBazAyRkFaaWk3ZkpDcTRiWnlvWk5YbWoxWDlnNkNONnhiUHh0RFhxQzdwMk41ZzFHaGgxQzdYbFBnSC1zOGFfeWE2ME81bWotbDFUbnlUVldqX0VsaFY5YmdFSzZuU3E0NjdMWXBnTTFLalFyWkM4aUVwMzBRb05UTXM?oc=5) |
| CNBC | Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxOZVpJVElUSGlmVjB5YjdSLVlIaEdOVklnYlJJaENoNzBDWE5felRFRzJmWk1WbUd6bGxBQUViNW02WlhOLXZZaTJ2c0dZUndZRGcwVklRMjhNb0ZUd2V6UEh2QW4xU3k0VXE3TDFIRlVKRWJITEctdm9zbTluaUpSUjlpeXlEckhrQXl1SXVKN2NBd2Q3NDN0RzNaT2IxUV9hM2FnYThB0gGrAUFVX3lxTE5tRUxDWHFDSDRUMnJsUmFkaWJvMWhpZkNyRnlMSUtzc0MtN3lnSWFkaUV2MjRwQXU1MDZQSDVZV0RRUGRJWmExSHlBalpleXkxb0JuVmRoYmkxS0FSUENVaTBMRVEyNjZabS1DMnBtbWVmUnVZVFJDMzlVOEdreDlDa1RzNWZaQlFTM0pQQ3U0QmtCWkZLQ0F4N3A4ZHBPXzZNdXY1YUNCM3dWWQ?) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-09-21/eli-lilly-ceo-tells-cnbc-one-third-of-new-glp-1-pill-patients-are-taking*